CLINICAL_TRIALS
trial_result
· 2018-09-13
Clinical Trial Update: Ketamine Co-induction for Patients With Major Depressive Disorder [Phase 4]
Summary
Clinical trial update for ketamine co-induction in major depressive disorder (Phase 4).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Saskatchewan | Conditions: Ketamine, Depression | Phase 4 | Status: UNKNOWN